The University of Chicago Medicine Comprehensive Cancer Center and Eli Lilly and Company have launched a two-year partnership aimed at...

A mathematical model developed by researchers at The University of Texas at Arlington may help resolve one of melanoma treatment’s...

A previously underexplored population of immune cells in the bone marrow may help explain why some patients with multiple myeloma...

A new randomized phase 3 study suggests that genetic risk profiling could help determine which patients with advanced epidermal growth...

PITTSBURGH, August 10, 2026 — Women living in socially vulnerable communities face a significantly higher risk of dying after an...

Gastric cancer may be exploiting a little-known metabolic molecule to disable the immune system, according to research from Keio University...

Triple-negative breast cancer has long presented one of oncology’s most difficult challenges: it lacks the three molecular markers—estrogen receptor, progesterone...

Glioblastoma is among the most aggressive and difficult-to-treat brain cancers, and a new study is drawing attention to an unexpected...

Lung cancer can leave behind a molecular fingerprint long after a surgeon has removed every visible tumor. In a study...

A new study in Nature Communications is drawing attention to a central question in cancer biology: why does the liver...